Manchester Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $800K | Buy |
33,216
+389
| +1% | +$10.2K | 0.1% | 125 |
|
|
2026
Q1 | $922K | Buy |
32,827
+2,584
| +9% | +$68.8K | 0.13% | 102 |
|
|
2025
Q4 | $753K | Sell |
30,243
-17,446
| -37% | -$440K | 0.1% | 122 |
|
|
2025
Q3 | $1.22M | Sell |
47,689
-2,316
| -5% | -$57.2K | 0.16% | 86 |
|
|
2025
Q2 | $1.21M | Buy |
50,005
+2,361
| +5% | +$55.1K | 0.16% | 93 |
|
|
2025
Q1 | $1.21M | Buy |
47,644
+507
| +1% | +$13.3K | 0.15% | 96 |
|
|
2024
Q4 | $1.25M | Buy |
47,137
+3,326
| +8% | +$90.2K | 0.15% | 93 |
|
|
2024
Q3 | $1.27M | Buy |
43,811
+301
| +0.7% | +$8.78K | 0.15% | 99 |
|
|
2024
Q2 | $1.22M | Buy |
43,510
+377
| +0.9% | +$10.4K | 0.15% | 90 |
|
|
2024
Q1 | $1.2M | Buy |
43,133
+247
| +0.6% | +$6.85K | 0.15% | 100 |
|
|
2023
Q4 | $1.23M | Sell |
42,886
-3,574
| -8% | -$108K | 0.17% | 89 |
|
|
2023
Q3 | $1.54M | Sell |
46,460
-203
| -0.4% | -$7.18K | 0.23% | 67 |
|
|
2023
Q2 | $1.71M | Buy |
46,663
+5,858
| +14% | +$228K | 0.23% | 65 |
|
|
2023
Q1 | $1.66M | Buy |
40,805
+79
| +0.2% | +$3.41K | 0.22% | 65 |
|
|
2022
Q4 | $2.09M | Sell |
40,726
-3,146
| -7% | -$151K | 0.31% | 44 |
|
|
2022
Q3 | $1.92M | Buy |
43,872
+1,252
| +3% | +$60.8K | 0.33% | 43 |
|
|
2022
Q2 | $2.23M | Buy |
42,620
+2,009
| +5% | +$102K | 0.38% | 36 |
|
|
2022
Q1 | $2.1M | Sell |
40,611
-2,830
| -7% | -$147K | 0.3% | 48 |
|
|
2021
Q4 | $2.56M | Sell |
43,441
-2,005
| -4% | -$99.3K | 0.34% | 41 |
|
|
2021
Q3 | $1.96M | Buy |
45,446
+2,743
| +6% | +$122K | 0.27% | 49 |
|
|
2021
Q2 | $1.67M | Buy |
42,703
+1,966
| +5% | +$76.5K | 0.23% | 60 |
|
|
2021
Q1 | $1.48M | Buy |
40,737
+1,340
| +3% | +$47.6K | 0.22% | 73 |
|
|
2020
Q4 | $1.45M | Sell |
39,397
-733
| -2% | -$26.9K | 0.22% | 66 |
|
|
2020
Q3 | $1.4M | Sell |
40,130
-9,529
| -19% | -$334K | 0.22% | 66 |
|
|
2020
Q2 | $1.54M | Hold |
49,659
| – | – | 0.21% | 59 |
|
|
2020
Q1 | $1.54M | Buy |
49,659
+3,206
| +7% | +$109K | 0.25% | 49 |
|
|
2019
Q4 | $1.73M | Buy |
46,453
+578
| +1% | +$20.6K | 0.19% | 56 |
|
|
2019
Q3 | $1.56M | Sell |
45,875
-419
| -0.9% | -$15.2K | 0.18% | 59 |
|
|
2019
Q2 | $1.9M | Sell |
46,294
-1,054
| -2% | -$41.9K | 0.24% | 52 |
|
|
2019
Q1 | $1.91M | Buy |
47,348
+2,581
| +6% | +$103K | 0.24% | 49 |
|
|
2018
Q4 | $1.54M | Hold |
44,767
| – | – | 0.24% | 44 |
|
|
2018
Q3 | $1.87M | Hold |
44,767
| – | – | 0.27% | 40 |
|
|
2018
Q2 | $1.54M | Buy |
44,767
+13,854
| +45% | +$473K | 0.23% | 44 |
|
|
2018
Q1 | $1.04M | Sell |
30,913
-518
| -2% | -$17.8K | 0.17% | 58 |
|
|
2017
Q4 | $1.08M | Buy |
31,431
+1,185
| +4% | +$40.4K | 0.16% | 58 |
|
|
2017
Q3 | $1.02M | Hold |
30,246
| – | – | 0.16% | 52 |
|
|
2017
Q2 | $964K | Hold |
30,246
| – | – | 0.15% | 59 |
|
|
2017
Q1 | $982K | Sell |
30,246
-1,063
| -3% | -$33.5K | 0.16% | 54 |
|
|
2016
Q4 | $965K | Sell |
31,309
-2,079
| -6% | -$63.5K | 0.15% | 61 |
|
|
2016
Q3 | $1.07M | Sell |
33,388
-8,655
| -21% | -$289K | 0.16% | 55 |
|
|
2016
Q2 | $1.4M | Hold |
42,043
| – | – | 0.2% | 44 |
|
|
2016
Q1 | $1.18M | Sell |
42,043
-13,704
| -25% | -$391K | 0.16% | 57 |
|
|
2015
Q4 | $1.71M | Sell |
55,747
-1,318
| -2% | -$41.5K | 0.24% | 46 |
|
|
2015
Q3 | $1.7M | Sell |
57,065
-9,486
| -14% | -$304K | 0.29% | 30 |
|
|
2015
Q2 | $2.12M | Buy |
66,551
+18,583
| +39% | +$606K | 0.34% | 26 |
|
|
2015
Q1 | $1.58M | Sell |
47,968
-105,217
| -69% | -$3.35M | 0.25% | 32 |
|
|
2014
Q4 | $4.53M | Sell |
153,185
-4,638
| -3% | -$133K | 0.56% | 14 |
|
|
2014
Q3 | $4.43M | Sell |
157,823
-42,792
| -21% | -$1.2M | 0.59% | 13 |
|
|
2014
Q2 | $5.65M | Sell |
200,615
-858
| -0.4% | -$24.5K | 0.75% | 13 |
|
|
2014
Q1 | $6.14M | Buy |
201,473
+1,560
| +0.8% | +$46.5K | 0.98% | 10 |
|
|
2013
Q4 | $5.81M | Sell |
199,913
-1,164
| -0.6% | -$33.9K | 0.91% | 11 |
|
|
2013
Q3 | $5.48M | Buy |
201,077
+46,639
| +30% | +$1.27M | 0.94% | 12 |
|
|
2013
Q2 | $4.1M | Buy |
+154,438
| New | +$4.27M | 0.76% | 14 |
|
Other funds holding PFE
Manchester Capital Management's PFE Position: Q2 2026 in Review
Manchester Capital Management increased its Pfizer (PFE) stake by 1.2% in Q2 2026, buying an estimated $10.2K and bringing the position to 33,216 shares worth $800K. The position accounts for 0.1% of the portfolio, ranked #125.
Manchester Capital Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.14M in Q1 2014. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Manchester Capital Management held 33,216 shares of Pfizer worth $800K as of Q2 2026.
- Manchester Capital Management bought 389 Pfizer shares in Q2 2026, an estimated $10.2K.
- Pfizer made up 0.1% of Manchester Capital Management's portfolio in Q2 2026, its #125 holding.
- Manchester Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Manchester Capital Management's Pfizer position peaked at $6.14M in Q1 2014.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Manchester Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.